Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

47 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Challenges and new approaches for the vaccine industry.
Bachmann MF, Jennings GT. Bachmann MF, et al. Among authors: jennings gt. Drug Discov Today. 2001 Jun 1;6(11):566-568. doi: 10.1016/s1359-6446(01)01811-6. Drug Discov Today. 2001. PMID: 11377223 No abstract available.
Virus-like particles as a modular system for novel vaccines.
Lechner F, Jegerlehner A, Tissot AC, Maurer P, Sebbel P, Renner WA, Jennings GT, Bachmann MF. Lechner F, et al. Among authors: jennings gt. Intervirology. 2002;45(4-6):212-7. doi: 10.1159/000067912. Intervirology. 2002. PMID: 12566703 Review.
Der p 1 peptide on virus-like particles is safe and highly immunogenic in healthy adults.
Kündig TM, Senti G, Schnetzler G, Wolf C, Prinz Vavricka BM, Fulurija A, Hennecke F, Sladko K, Jennings GT, Bachmann MF. Kündig TM, et al. Among authors: jennings gt. J Allergy Clin Immunol. 2006 Jun;117(6):1470-6. doi: 10.1016/j.jaci.2006.01.040. Epub 2006 Apr 27. J Allergy Clin Immunol. 2006. PMID: 16751015 Clinical Trial.
A vaccine for hypertension based on virus-like particles: preclinical efficacy and phase I safety and immunogenicity.
Ambühl PM, Tissot AC, Fulurija A, Maurer P, Nussberger J, Sabat R, Nief V, Schellekens C, Sladko K, Roubicek K, Pfister T, Rettenbacher M, Volk HD, Wagner F, Müller P, Jennings GT, Bachmann MF. Ambühl PM, et al. Among authors: jennings gt. J Hypertens. 2007 Jan;25(1):63-72. doi: 10.1097/HJH.0b013e32800ff5d6. J Hypertens. 2007. PMID: 17143175 Clinical Trial.
47 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page